Prostate Cancer Medical Research News

A 70-year-old male having advanced prostate cancer presenting with hypercalcemia and diffuse osteoblastic bone metastases: a case report
A 70-year-old male having advanced prostate cancer presenting with hypercalcemia and diffuse osteoblastic bone metastases: a case report Bony metastases were occasionally the initial presentation
Algeta Completes Comprehensive Phase II Clinical Program With Alpharadin for Treating Bone Metastases in Patients With Advanced Prostate Cancer
Algeta Completes Comprehensive Phase II Clinical Program With Alpharadin for Treating Bone Metastases in Patients With Advanced Prostate Cancer OSLO, Norway, January 14 /PRNewswire-FirstCall/ --
GTx Fareston may find success in the prevention of prostate cancer-associated bone fractures
GTx Fareston may find success in the prevention of prostate cancer-associated bone fractures Published:24-February-2009 By Datamonitor staff writer GTx has filed a New Drug Application for Fare
Hampton University developing proton-beam cancer treatment center
Hampton University developing proton-beam cancer treatment center By TAMMIE SMITH Published: February 28, 2009 In the war on cancer, protons may be about to take center stage as universities acro
Methodist Health System Prostate Cancer Screening Program Wins Statewide Community Service Award
Methodist Health System Prostate Cancer Screening Program Wins Statewide Community Service Award AUSTIN, Texas, Jan. 22 /PRNewswire-USNewswire/ -- Methodist Dallas Medical Center has been named the
Natural 'defence' gene reveals how oestrogen fuels cancer
Natural 'defence' gene reveals how oestrogen fuels cancer Published: Tuesday, 13-Jan-2009 Printer Friendly Medical Research News CANCER RESEARCH UK scientists have shown for
Negative Findings Of Major Prostate Cancer Trial Support AICR Recommendation On Supplement Use
Negative Findings Of Major Prostate Cancer Trial Support AICR Recommendation On Supplement Use Article Date: 13 Jan 2009 - 3:00 PST New data published in the January 7 issue of the Journal o
Prostate Cancer Genetic Testing - Is it real or is it boutique lab work?
Prostate Cancer Genetic Testing - Is it real or is it boutique lab work? Analysis of: Clarient Launches Gene Expression Test for Prostate Cancer (www.medcompare.com) This analysis is solely the work
PSA Tests Not Race-Specific, Study Finds
PSA Tests Not Race-Specific, Study Finds Contrary to common belief, same threshold works well for black and white men, researchers say Posted February 24, 2009 TUESDAY, Feb. 24 (HealthDay News)
Targeted Prostate Cancer Biopsy and Cancer Treatment Earns Acceptance From Nation's Top Prostate Specialists
Targeted Prostate Cancer Biopsy and Cancer Treatment Earns Acceptance From Nation's Top Prostate Specialists TargetScan(R) Technology passes 3,500-procedure milestone as the system becomes availabl
Targeted Prostate Cancer Biopsy and Cancer Treatment Earns Acceptance From Nation's Top Prostate Specialists
Targeted Prostate Cancer Biopsy and Cancer Treatment Earns Acceptance From Nation's Top Prostate Specialists TargetScan(R) Technology passes 3,500-procedure milestone as the system becomes availabl
Thalidomide 'may help fight cancer'
Thalidomide 'may help fight cancer' Jan 22, 2009 Thalidomide, the drug that blighted a generation in the 1960s, may be helpful in treating prostate cancer, doctors have found. Prostate cancer tha
Theraputic target for prostate cancer :The report, entitled Cytosolic Phospholipase A2-: A Potential Therapeutic Target for Prostate Cancer, describes the possible role of an enzyme called cPLA2- in prostate cancer and its potential to be a treatment targ
Theraputic target for prostate cancer Published: Wednesday, 14-Jan-2009 Men's Health News The report, entitled Cytosolic Phospholipase A2-: A Potential Therapeutic Target for Prostate